Menopausal women suffering from moderate to severe hot flashes could gain a new non-hormonal treatment option after successful clinical trials led by the U.Va. School of Medicine.
Recent Articles by
August 21, 2012
Two years after changing the way it trains future doctors, the U.Va. School of Medicine is overhauling how it prepares the biomedical scientists of tomorrow.
July 12, 2012
July 12, 2012 — Of the 43,000 Americans diagnosed with pancreatic cancer each year, only 10 percent to 15 percent are diagnosed early enough to receive potentially lifesaving surgery.
June 29, 2012
June 29, 2012 — Should high school athletes and prospective military personnel be genetically tested to determine if they are at increased risk for dementia caused by repeated head injuries?
June 21, 2012
June 21, 2012 — Kidney injuries among high school varsity athletes are so rare that even youth with only one kidney should be allowed to play, researchers at the University of Virginia School of Medicine have concluded after conduc
June 20, 2012
A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has found.
June 19, 2012
Groundbreaking cancer research at the University of Virginia School of Medicine has discovered a previously unknown way genes can fuse into "chimera" – named for a mythical beast with the head of a lion and body parts of other anima
June 15, 2012
June 15, 2012 — Bisphenol A, or BPA – a chemical that commonly leaches into food and drink from cans and plastic containers – can alter the behavior of mice for generations after exposure, research led by the University of Virginia School
May 18, 2012
UVA Today is highlighting the winners of the 2012 Leonard W. Sandridge Outstanding Contribution Awards, the highest U.Va. honor staff receive for their dedicated service to the University. Today: Souradji Issotouof U.Va.'s Health System.
March 29, 2012
March 29, 2012 — Researchers led by Jonathan Kipnis at the University of Virginia School of Medicine have, for the first time, used an immune therapy to halt the symptoms of Rett syndrome, an autism spectrum disorder, in test mice.